What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
about
Hospital epidemiology and infection control in acute-care settings.Risk factors and prevalence of high resistant Acinetobacter spp among hospitalized patients.Comparison of PCR/electron spray ionization-time-of-flight-mass spectrometry versus traditional clinical microbiology for active surveillance of organisms contaminating high-use surfaces in a burn intensive care unit, an orthopedic ward and healthcaLimits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward.Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental studyPreventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.Patterns of ciprofloxacin-resistant gram-negative bacteria colonization in nursing home residentsExtended-spectrum beta-lactamase--producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission.Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysisAcinetobacter baumannii: an emerging multidrug-resistant threat.The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities.Antimicrobial stewardship--the state of the art in 2011: focus on outcome and methods.Time-series analysis of the relationship of antimicrobial use and hand hygiene promotion with the incidence of healthcare-associated infections.[Update on outbreaks reported from neonatal intensive care units: Serratia marcescens, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa].Sensitivity of surveillance testing for multidrug-resistant Gram-negative bacteria in the intensive care unit.Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.Antimicrobial drug use and antibiotic-resistant bacteria.Increasing prevalence of gastrointestinal colonization with ceftazidime-resistant gram-negative bacteria among intensive care unit patients.When should contact precautions and active surveillance be used to manage patients with multidrug-resistant enterobacteriaceae?A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.Impact of single room design on the spread of multi-drug resistant bacteria in an intensive care unit.Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper .Epidemiology of multidrug-resistant bacteria in patients with long hospital stays.Clinical Microbiology and Infection Prevention.UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study.
P2860
Q30429049-E575CFF5-5E99-4CBE-9ACE-AF976ACF6DD9Q33977380-DC3BCDA8-797F-4975-AE48-5C7B4131B021Q34438946-FC9D4BE7-56A0-4208-82C3-4AF62E77DAB0Q34687402-2AB07E82-A333-43AE-83B8-920003DC7935Q35131933-3E1AE400-EE9D-456A-A114-413D30AC2A25Q35738292-900E0B87-3749-4372-9A0E-88DFF660509FQ35870393-FADE981F-5AE2-440F-AF18-10D7CDBD3A76Q35988906-CA03C051-3D30-4361-872B-88E80373CF13Q36662088-01920E4B-D192-4C98-85DA-73C381010A2CQ37202840-04DFCE59-4C71-400A-BA75-3FDAC045FD20Q37214297-540ABF54-7173-4121-9065-BB12A3641EC9Q37993711-C71495DC-7738-4EA1-9B1C-0468958CFD57Q39619903-F38C3683-EA47-4886-AA4B-0D44D1F7D070Q41493778-3295409E-8FB2-4240-9FAA-486BE627601EQ41945205-9CFBE53E-2119-434A-ACCF-AB219A8DC7EDQ42275030-480304DD-17F1-41E5-B9FD-418C70D40A7EQ43108529-F92A4F92-197D-4883-AEDC-471B063AD576Q43230466-15CC88D4-3E32-4DE4-80DA-44BE2F4EFA98Q43570076-4C6BD89F-6872-4BE7-B92B-58D60ABDDA4AQ43840285-5E64B632-7F2A-4E35-AD5B-D57C3F099E10Q44437717-6B491B6D-D970-4FE4-8589-EADF6A6782FDQ45035171-562806A2-2332-469D-9865-11B755ED284FQ46353502-3B3A757F-40B1-421C-8F75-D304E34F908BQ46958415-7A9F360A-625E-484A-B2D5-50E078572B95Q47126864-569BFC68-F9BA-4FA6-93E6-4E968D1782DBQ53205620-3419FA86-1D0E-4B71-8E14-3E1A73B135A4
P2860
What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
What infection control interve ...... istant gram-negative bacteria?
@ast
What infection control interve ...... istant gram-negative bacteria?
@en
type
label
What infection control interve ...... istant gram-negative bacteria?
@ast
What infection control interve ...... istant gram-negative bacteria?
@en
prefLabel
What infection control interve ...... istant gram-negative bacteria?
@ast
What infection control interve ...... istant gram-negative bacteria?
@en
P2860
P356
P1476
What infection control interve ...... istant gram-negative bacteria?
@en
P2093
Anthony D Harris
Jon P Furuno
P2860
P304
P356
10.1086/504479
P407
P478
43 Suppl 2
P577
2006-09-01T00:00:00Z